NTUH
Hsinchu, 300, Taiwan
Location status: Recruiting
NCT Number: NCT06513403
Through artificial intelligence technology, we have conducted a preliminary study aimed at identifying differences in facial expressions among healthy individuals, patients with cognitive decline, and dementia patients. This research offers a novel method and tool for dementia screening, contributing to effective strategies for dementia prevention in our country. By utilizing this approach, we can effectively delay the onset of disability, promote healthy aging among our elderly population, reduce the caregiving burden on individuals, families, and society, and lower medical expenses.
Interested in participating?
Request Info50 year–75 year
All sexes
Observational
Hsinchu, 300, Taiwan
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Age between 50 and 75 years.
Time frame: 2024/8/1-2025/10/31
(A) Participants will sit in front of a computer screen and watch videos depicting positive (happy) or negative (sad) emotional stimuli. Each video will be less than 60 seconds long. (B) Participants will undergo the memory recall and calculation ability tests included in the MMSE. (C) While participants are undergoing the tests, video recording equipment will be used to observe and record the facial expression responses of the three groups.
Contact information is provided by the study sponsor or research team.
National Taiwan University Hospital
Other
Preliminary Study Using Artificial Intelligence Technology to Identify Differences in Facial Expressions Between Healthy People, Patients With Cognitive Decline, and Patients With Dementia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06624605
Artificial Intelligence (AI), Artificial Intelligence Technology
Rochester, Minnesota, United States
View Trial DetailsNCT05592678
Alzheimer Disease, Alzheimer's Disease (AD)
San Antonio, Texas, United States
View Trial DetailsNCT06052397
Brain Diseases, Central Nervous System Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT06411561
Alzheimer Disease, Alzheimer's Disease
Seattle, Washington, United States
View Trial Details